HK1171218A1 - Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4- iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane- 1-sulfonamide and protected derivatives thereof (r)(s)-n-(34--2-(2--4-)-6-)-1-(23-) -1- - Google Patents

Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4- iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane- 1-sulfonamide and protected derivatives thereof (r)(s)-n-(34--2-(2--4-)-6-)-1-(23-) -1-

Info

Publication number
HK1171218A1
HK1171218A1 HK12112020.5A HK12112020A HK1171218A1 HK 1171218 A1 HK1171218 A1 HK 1171218A1 HK 12112020 A HK12112020 A HK 12112020A HK 1171218 A1 HK1171218 A1 HK 1171218A1
Authority
HK
Hong Kong
Prior art keywords
iodophenylamino
dihydroxypropyl
cyclopropane
sulfonamide
difluoro
Prior art date
Application number
HK12112020.5A
Other languages
English (en)
Chinese (zh)
Inventor
．馬代爾納
．韋尼耶
Original Assignee
阿迪生物科學公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42830488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1171218(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 阿迪生物科學公司 filed Critical 阿迪生物科學公司
Publication of HK1171218A1 publication Critical patent/HK1171218A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/80—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by distillation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK12112020.5A 2009-07-24 2012-11-23 Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4- iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane- 1-sulfonamide and protected derivatives thereof (r)(s)-n-(34--2-(2--4-)-6-)-1-(23-) -1- HK1171218A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22850109P 2009-07-24 2009-07-24
US22850909P 2009-07-24 2009-07-24
PCT/EP2010/004222 WO2011009541A1 (en) 2009-07-24 2010-07-10 Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof

Publications (1)

Publication Number Publication Date
HK1171218A1 true HK1171218A1 (en) 2013-03-22

Family

ID=42830488

Family Applications (2)

Application Number Title Priority Date Filing Date
HK12112020.5A HK1171218A1 (en) 2009-07-24 2012-11-23 Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4- iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane- 1-sulfonamide and protected derivatives thereof (r)(s)-n-(34--2-(2--4-)-6-)-1-(23-) -1-
HK14111856A HK1198364A1 (zh) 2009-07-24 2014-11-24 酶抑制劑的中間體

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK14111856A HK1198364A1 (zh) 2009-07-24 2014-11-24 酶抑制劑的中間體

Country Status (32)

Country Link
US (3) US8513443B2 (es)
EP (1) EP2462111B1 (es)
JP (1) JP5776115B2 (es)
KR (1) KR101763437B1 (es)
CN (2) CN103848808B (es)
AR (1) AR079183A1 (es)
AU (1) AU2010275780B2 (es)
BR (1) BR112012001592A2 (es)
CA (2) CA2990097A1 (es)
CL (1) CL2012000192A1 (es)
CO (1) CO6491075A2 (es)
CR (1) CR20120044A (es)
CU (1) CU24113B1 (es)
DO (1) DOP2012000017A (es)
EA (1) EA023623B1 (es)
EC (1) ECSP12011621A (es)
GT (1) GT201200017A (es)
HK (2) HK1171218A1 (es)
HN (1) HN2012000142A (es)
IL (1) IL217312A (es)
IN (1) IN2012DN00696A (es)
MA (1) MA33452B1 (es)
MX (2) MX2012001063A (es)
MY (1) MY160421A (es)
NZ (1) NZ597738A (es)
PE (1) PE20120573A1 (es)
PH (1) PH12014500158A1 (es)
SG (1) SG177535A1 (es)
TN (1) TN2012000027A1 (es)
TW (1) TWI524890B (es)
UY (1) UY32800A (es)
WO (1) WO2011009541A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 （ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備
EP2714652B8 (en) * 2011-05-27 2018-09-05 Ardea Biosciences, Inc. Chiral synthesis of n-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl]cyclopropanesulfonamides
CN104011039A (zh) * 2011-12-19 2014-08-27 住友化学株式会社 磺酸盐的制造方法
EP2848246A1 (en) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Pharmaceutical compositions containing refametinib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101799B2 (en) * 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
SI1912636T1 (sl) * 2005-07-21 2014-08-29 Ardea Biosciences, Inc. N-(arilamino)-sulfonamidni inhibitorji MEK
WO2007121269A2 (en) * 2006-04-11 2007-10-25 Ardea Biosciences, Inc. N-aryl-n'alkyl sulfamides as mek inhibitors
JP5269762B2 (ja) 2006-04-18 2013-08-21 アーディア・バイオサイエンシーズ・インコーポレイテッド Ｍｅｋ阻害剤としてのピリドンスルホンアミドおよびピリドンスルファミド
JP5479337B2 (ja) * 2007-07-30 2014-04-23 アルディア バイオサイエンス，インク． Ｍｅｋ阻害剤およびｒａｆキナーゼ阻害剤の組み合わせ、ならびにその使用
AU2009236325A1 (en) * 2008-04-14 2009-10-22 Ardea Biosciences, Inc. Compositions and methods for preparing and using same
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 （ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備

Also Published As

Publication number Publication date
CA2990097A1 (en) 2011-01-27
BR112012001592A2 (pt) 2016-03-08
CN102471246B (zh) 2015-08-26
PH12014500158B1 (en) 2015-09-07
MX344965B (es) 2017-01-12
IL217312A (en) 2017-02-28
AR079183A1 (es) 2012-01-04
MY160421A (en) 2017-03-15
CR20120044A (es) 2012-03-12
AU2010275780A1 (en) 2012-02-02
CU20120014A7 (es) 2012-06-21
IN2012DN00696A (es) 2015-06-19
MX2012001063A (es) 2012-03-26
GT201200017A (es) 2013-12-19
HK1198364A1 (zh) 2015-04-10
TW201113017A (en) 2011-04-16
KR101763437B1 (ko) 2017-07-31
ECSP12011621A (es) 2012-02-29
MA33452B1 (fr) 2012-07-03
CA2768788A1 (en) 2011-01-27
IL217312A0 (en) 2012-02-29
US20130261320A1 (en) 2013-10-03
CN103848808B (zh) 2016-02-10
US8884058B2 (en) 2014-11-11
EA201200175A1 (ru) 2012-12-28
CL2012000192A1 (es) 2012-10-05
JP5776115B2 (ja) 2015-09-09
EP2462111B1 (en) 2016-03-30
JP2013500242A (ja) 2013-01-07
CA2768788C (en) 2018-01-09
CN102471246A (zh) 2012-05-23
UY32800A (es) 2011-01-31
WO2011009541A1 (en) 2011-01-27
SG177535A1 (en) 2012-03-29
US8513443B2 (en) 2013-08-20
TWI524890B (zh) 2016-03-11
PE20120573A1 (es) 2012-05-17
CU24113B1 (es) 2015-08-27
AU2010275780B2 (en) 2015-10-22
US20120178946A1 (en) 2012-07-12
US9296686B2 (en) 2016-03-29
EP2462111A1 (en) 2012-06-13
HN2012000142A (es) 2015-06-08
DOP2012000017A (es) 2012-05-15
NZ597738A (en) 2014-03-28
KR20120032536A (ko) 2012-04-05
EA023623B1 (ru) 2016-06-30
CN103848808A (zh) 2014-06-11
TN2012000027A1 (en) 2013-09-19
PH12014500158A1 (en) 2015-09-07
CO6491075A2 (es) 2012-07-31
US20150274651A1 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
EP2150109A4 (en) PHARMACEUTICAL USE OF SUBSTITUTED AMIDES
IL238607A (en) Derivatives n - [(cyclic group) sulfonyl] benzamide and their use
IL191035A0 (en) Pharmaceutical use of substituted amides
PL2120921T3 (pl) Zastosowanie kwasu aminolewulinowego i jego pochodnych
HK1145319A1 (en) Icotinib hydrochloride, synthesis, crystallographic form, medical combination, and uses thereof
IL221782A (en) Agomalatine Hydrochloride Hydrate and its Pharmaceutical Preparations
HK1174628A1 (zh) -取代的磺酰氧基苄胺類和相關化合物的化妝品應用
IL220586A (en) Carboxamide compound, a pharmaceutical composition containing it and its use
ZA201103516B (en) Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
HK1171218A1 (en) Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4- iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane- 1-sulfonamide and protected derivatives thereof (r)(s)-n-(34--2-(2--4-)-6-)-1-(23-) -1-
IL210921A0 (en) Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
HUP1000327D0 (en) Composition containing nanostructured ezetibime and process for it's preparation
HK1123998A1 (en) Pharmaceutical preparation containing garcinia acid and use thereof
IL221783A (en) Agomalatine Hydrobromide Hydrate and its Pharmaceutical Preparations
PL2430919T3 (pl) Kompozycje biocydowe zawierające amidy na bazie kwasu furano-2-karboksylowego i jego pochodnych
UA106762C2 (uk) Спосіб одержання (r)- та (s)-n-(3,4-дифтор-2-(2-фтор-4-йодфеніламіно)-6-метоксифеніл)-1-(2,3-дигідроксипропіл)циклопропан-1-сульфанаміду та його захищених похідних
HK1214585A1 (zh) -二甲基氨基-丙烯酰基 -氟-苯基 -甲基-乙酰胺的製備方法
GB201019043D0 (en) Use of 2',5'-oligoadenylate derivative compounds
IL191861A0 (en) Improved jasmonate derivatives, pharmaceutical compositions and methods of use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190704